A Japan-based study found rising cases of therapy-related acute myeloid leukemia (tAML), particularly among breast cancer survivors. Caused by chemotherapy- or radiation-induced DNA damage, tAML remains aggressive. Researchers noted that its incidence has increased over decades, highlighting the need for long-term monitoring and improved treatment strategies for cancer survivors.